Antineoplastic drugs are clearly beneficial for patients but there is concern about the health risk to healthcare workers handling them 1) . Usually, antineoplastic drugs are mixed and diluted as infusions by health care workers, then administered to patients. In these processes, the air, workbenches, clothes, medical equipment used and excrement of the patients may be contaminated by the antineoplastic drugs 2) . Healthcare workers are exposed to antineoplastic drugs via inhalation, skin contact, eye contact and oral ingestion 2) . Some antineoplastic drugs are known to induce cytotoxicity, genotoxicity and carcinogenicity 3, 4) . Increases in hair loss, skin rash, infertility, miscarriage, birth defects, chromosomal aberrations, sister chromatid exchanges, and DNA strand break have been observed among healthcare workers handling antineoplastic drugs 2, [5] [6] [7] [8] [9] [10] [11] . Guidelines for safe handling of antineoplastic drugs were formulated in 1981, 1981, 1983 and 1990 in Australia, Canada, England, and America, respectively [12] [13] [14] [15] . In Japan, guidelines for handling antineoplastic drugs in the hospital were issued by the Japan Pharmaceutical Association in 1991 16) . However, the extent of the implementation of these guidelines is unknown. Ishii et al. reported that in a survey of 313 hospitals in Japan in 2001, 40% of the nurses were not aware of the potential adverse effects of occupational exposure to antineoplastic drugs 17) . In 2004, we investigated the genotoxic risks of nurses handling antineoplastic drugs in Japan. We found that the nurses
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had been exposed to these drugs and suggested that lymphocyte DNA damage could had been induced by such drugs 18) . In the present study, we conducted a questionnaire survey in order to identify the conditions under which antineoplastic drugs are mixed in hospitals.
Methods
All 155 hospitals with 100 or more beds for general patients in Osaka Prefecture as of April 2006 were selected for the questionnaire survey. Two types of questionnaire were used. One asked about the occurrence of mixing operations and job descriptions related to them. The other questionnaire asked for details on the conditions of the mixing operations, including their frequency, types of antineoplastic drugs handled, awareness of occupational exposure to antineoplastic drugs, the need for systematic education on the mixing of antineoplastic drugs, health concerns due to exposure to antineoplastic drugs, implementation of guidelines, the existence of biological safety cabinets and workbenches dedicated to the handling of antineoplastic drugs, the use of personal protective equipment, the use of sterilized sheets and spill kits, the adoption of techniques to retain negative pressure in the vial, the disposal procedures of clinical waste related to antineoplastic drug use and the excrement of patients treated with antineoplastic drugs, and the occurrence of accidents during the mixing operation. These questionnaires were sent to the hospitals in July 2006 and responses were received from August to October 2006.
Of the 155 hospitals, 107 responded to our questionnaire (69.0%). Antineoplastic drugs were mixed in 87 of the 107 hospitals (81.3%). The questionnaires were answered by doctors in 17.2% of the hospitals, nurses in 11.5%, and pharmacists in 70.1%. In the present study, the median number of beds in the 87 hospitals in which antineoplastic drugs were handled was 332. Hospitals with less than 332 beds and those with 332 or more beds were classified as small-scale and large-scale, respectively. Comparison of the mean values of the two groups was conducted using the t test. Comparison of the percentages of the two groups was conducted using Fisher's exact test. These calculations were conducted using SPSS 12.0 J software (SPSS Japan Inc, Japan).
Results

Job description, frequency of mixing operation and frequency of handling antineoplastic drugs
The antineoplastic drugs were mixed by doctors in 58.6% of the hospitals, nurses in 44.8%, and pharmacists in 63.2% (multiple answers).
The mean frequency of the mixing operation was 8.8 (0.5-25) d per month per worker. The mean frequencies in small-and large-scale hospitals were 8.5 and 9.0 days per month per worker, respectively, with the difference not being significant.
The mean number of antineoplastic drugs handled was 7.4 (1-18) types excluding the response "using almost all antineoplastic drugs" (n=1). Table 1 lists the antineoplastic drugs used in 5 or more hospitals. The mean number of antineoplastic drugs used was 6.1 and 8.8 types, respectively, for small-and large-scale hospitals, with the difference being significant (p=0.002).
Awareness of occupational exposure to antineoplastic drugs
Occupational exposure to antineoplastic drugs was recognized in 97.7% of the hospitals. The need for systematic education on the mixing of antineoplastic drugs was recognized in 93.1% of the hospitals. In 88.5% of the hospitals, the respondents felt concern about the adverse effects on their own health due to exposure to antineoplastic drugs. When the answers were classified by job description, occupational exposure to antineoplastic drugs was recognized by 86.7% of the doctors, 90.0% of the nurses and 100% of the pharmacists. The need for systematic education on the mixing of antineoplastic drugs was recognized by 86.7% of the doctors, 100% of the nurses and 95.1% of the pharmacists. Among the doctors, nurses and the pharmacists, respectively 66.7%, 90.0% and 95.1% of the respondents felt concern about adverse effects on their own health from exposure to antineoplastic drugs. In the present study, we did not compare the awareness of occupational exposure to antineoplastic drugs with job description by statistical test, because the sample number was not large enough.
Safety precautions
The status of safety precautions related to the mixing operation is given in Table 2 . The percentages of use of guidelines were significantly (p=0.005) lower in smallscale hospitals than in than large-scale hospitals. Also, the percentages of installation of biological safety cabinets were significantly (p<0.001) lower in small-scale hospitals than in large-scale hospitals. A ventilation fan only had been installed in 21.3% of the hospitals, and neither cabinet nor fan in 21.3%.
The mixing operation was done on a workbench dedicated to the handling of antineoplastic drugs in 44.8% of the hospitals. The percentages of exclusive-use workbenches were significantly (p=0.002) lower in smallscale hospitals than in large-scale hospitals, and the percentages of exclusive-use workbenches were 72.0 and 8.8%, respectively, for hospitals with and without a biological safety cabinet (p<0.001, Fisher's exact test). In 48.3% of the hospitals, non-antineoplastic drugs were also handled on the workbench for handling antineoplastic drugs, and in 6.9% of the hospitals, even office work was done on the same workbench.
Gloves, mask, gown and goggles were available in 82.7, 69.0, 62.1 and 36.8% of the hospitals, respectively.
The percentages of gown equipment were significantly (p=0.044) lower in small-scale hospitals than in largescale hospitals. In 29.2% of the hospitals in which gloves were used, they were worn doubly. No personal protective equipment was used in 10.1% of the hospitals.
To trap antineoplastic drug spill, a sterilized sheet made of absorbent material can be laid out on the workbench. A spill kit can also be used, consisting of gloves, mask, gown, goggles and a sterilized sheet to prevent contamination from antineoplastic drugs due to accidental spilling. A sterilized sheet and a spill kit were used in 57.5% and 21.8%, respectively, of the hospitals. The percentages of use of sterilized sheet were significantly (p=0.016) lower in small-scale hospitals than in largescale hospitals. Sterilized sheets were used in 56.8% of the hospitals when workers wore a single pair of gloves, and in 90.4% of the hospitals when workers wore a double pair of gloves (p=0.006, Fisher's exact test).
In order to avoid the spread of antineoplastic drugs in the mixing operation, the vial should be kept under negative pressure 16) . A technique for doing this had been adopted by 75.9% of the hospitals. The percentages of implementation of this technique were significantly (p=0.009) lower in small-scale hospitals than in largescale hospitals. Table 3 shows the status of the disposal process of 
Disposal process of clinical waste from antineoplastic drug use and excrement of patients treated with antineoplastic drugs
Accidents during the mixing operation
In 43.7% of the hospitals, the respondents had experienced accidents during antineoplastic drug preparation, including the drugs adhering to hands or eyes, drug leakage, accidental injection and cutting by ampoules.
Discussion
We conducted a questionnaire survey in order to identify the conditions under which antineoplastic drugs are mixed in hospitals in Osaka Prefecture. Mixing of antineoplastic drugs was done in 81.3% of the hospitals. It seems to be a routine procedure in general hospitals, not being limited to university hospitals or specialist cancer chemotherapy centers.
Ishii et al. reported that the mixing of antineoplastic drugs was done by doctors in 29.9% of the hospitals surveyed in 2000, by nurses in 55.2%, and by pharmacists in 0.7% 17) . In the present study, the antineoplastic drugs were mixed by doctors in 58.6% of the hospitals, nurses in 44.8%, and pharmacists in 63.2%, with an increase in the rate of pharmacists over the past 6 yr. One factor has been the revision of the medical treatment fee under which a national insurance point is now added when pharmacists mix antineoplastic drugs.
The mean frequency of the mixing operation was 8.8 d per month per worker, with no difference being observed between small-and large-scale hospitals. Consequently, the possibility of exposure to antineoplastic drugs did not seem to depend on the scale of the hospital. In the present study, we asked about the frequency of the mixing operation, not the amount of antineoplastic drugs handled. As many kinds of antineoplastic drugs were used in the hospitals and their toxicity evaluation varied, we could not adopt a standard representation of the amount handled. The mean number of antineoplastic drugs handled was 7.4 types, with large-scale hospitals handling more types than small-scale ones. The number of types of antineoplastic drugs seemed to depend on the scale of the hospital.
Most respondents were aware of the occupational exposure to antineoplastic drugs. We did not compare awareness of occupational exposure to antineoplastic drugs with job description, because the sample number was not large enough. Awareness of antineoplastic drugs may differ with job description, further studies are necessary.
Guidelines for the safe handling of antineoplastic drugs had been adopted by 52.8% of the hospitals surveyed, with the rate being higher for large-scale hospitals than small-scale ones. Ishii et al. reported that 9.8% of the hospitals had adopted guidelines within the prior six years 17) . Biological safety cabinets had been installed in 57.4% of the hospitals, with more being found in largescale hospitals than in small-scale hospitals. The mixing of non-antineoplastic drugs or usual office work was done on the workbench for handling antineoplastic drugs in 91.2% of the hospitals which had not installed a biological safety cabinet. Studies have reported that workbenches for handling antineoplastic drugs were contaminated by antineoplastic drugs [18] [19] [20] . Conducting the mixing of nonantineoplastic drugs or office work on a workbench used for handling antineoplastic drugs was likely to lead to contamination of other patients and health care workers. We recommend that the workbench for mixing antineoplastic drugs be separated from the space used by other health care workers.
The results related to protective equipment for personal wear, such as gloves, mask, gown and goggles, revealed that goggles were not used in more than 60% of the hospitals. With respect to gloves, as some antineoplastic drugs have been reported to permeate through them, wearing double gloves and changing them within a specified time (30 to 60 min) are recommended 2, 16, 21) . In some guidelines, using sterilized sheets and a spill kit are recommended 2, 16) . In 29.2% of the hospitals using gloves, they were worn doubly, and sterilized sheets were used in 90.4% of these hospitals. These hospitals abided by the guidelines, indicating strong interest in the safe handling of antineoplastic drugs. In the present study, the lowest percentage of use was recorded for goggles. Ben-Ami et al. reported that health care workers felt awkward wearing goggles 22) . We observed similar results in our present study. However, as our study revealed a risk of antineoplastic drugs entering the eyes, the use of goggles should be promoted. In 10.1% of the hospitals, personal protective equipment was not used. As the hands or gloves of health care workers who handle antineoplastic drugs have been reported to be contaminated by antineoplastic drugs, all workers handling antineoplastic drugs should wear suitable personal protective equipment 19, 20) . The technique of retaining negative pressure in the vial was being used in 75.9% of the hospitals. Many healthcare workers seemed to use this technique, even though special training is needed to master it.
Occupational exposure to antineoplastic drugs and its risk were recognized as a health risk in 97.7% of the hospitals, but implementation of safety precautions for handling antineoplastic drugs had been adopted in greater measure by the large-scale hospitals. Because the mixing operation of antineoplastic drugs was done in 81.3% of the hospitals surveyed and there is no significant difference in the mean frequencies between small-and large-scale hospitals, safety precautions must be adopted by all hospitals.
Used vials and ampoules were disposed of as unburnable wastes by 19.5% of the hospitals. As used vials, ampoules, syringes and personal protective equipment can be contaminated by antineoplastic drugs, they should be disposed of in exclusive waste containers. Proper treatment of this waste will protect healthcare workers and cleaners from antineoplastic drug contamination. The safety measures related to the handling of excrement of patients treated with antineoplastic drugs were not used by many of the hospitals. This can be problematic as many antineoplastic drugs are excreted in the urine and/or feces; up to 25% of cyclophosphamide administered is excreted in urine as the unchanged substance for 24 h 23) . The excrement of patients treated with antineoplastic drugs within 48 h should be handled with protection equipment 2) . Methods of handling patient excrement are not described in the guidelines issued by the Japan Pharmaceutical Association, and need to be established.
In 43.7% of the hospitals, the respondents had experienced accidents during antineoplastic drug preparation. As countermeasures against many of the accidents reported in our survey are listed in the guidelines, promoting understanding of these guidelines should aid in their prevention 16) . A further problem arises with ampoules, which can cause cutting and can lead to the vaporization of residual drugs. Pharmaceutical companies should replace the ampoule form with a safer type of container.
Conclusions
The mixing operation of antineoplastic drugs was found to be a common practice in the hospitals surveyed, and most respondents recognized the possibility of occupational exposure to antineoplastic drugs and its risks. The percentages of hospital staff participating in the mixing operation were about the same for doctors, nurses and pharmacists. Guidelines and a biological safety cabinet were in use in about half of the hospitals, and personal protective equipment, with the exception of goggles, were used in many hospitals. In small-scale hospitals, the adoption of many of the safety precautions had not been implemented. Most hospitals did not employ safety measures for handling the excrement of patients treated with antineoplastic drugs. Further consideration of the safety guidelines regarding the handling of antineoplastic drugs and their stricter implementation are strongly recommended.
